Long-term survival and cure fraction estimates for paediatric central nervous system tumours in 31 European countries (EUROCARE-6): a population-based study

Central Nervous System Tumors

Survival of European adolescents and young adults diagnosed with central nervous system tumours and comparison with younger and older age groups: EUROCARE-6 results

Eur J Cancer

McCabe M, Rossi S, Cerza F, Massimino M, Gianno F, Spycher BD, Marcos-Gragera R, Bennett D, Lasalvia P, Didonè F, El Karoui NJ, Ragusa R, Mayer-da-Silva A, Mousavi SM, Trama A, EUROCARE-6 WG

doi: 10.1016/j.ejca.2025.115661

Further Publications

Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study

Eur J Cancer

Trama A, Bernasconi A, Cañete A, Carulla M, Daubisse-Marliac L, Rossi S, De Angelis R, Sanvisens A, Katalinic A, Paapsi K, Went P, Mousavi M, Blum M, Eberle A, Lamy S, Capocaccia R, Didonè F, Botta L, EUROCARE-6 WG

doi: 10.1016/j.ejca.2024.115147

Lymphoma

Secondary central nervous system lymphoma (SCNSL) in mantle cell lymphoma (MCL): Characteristics and risk factors in a Danish nationwide population-based study

Br J Haematol

Trab T, Ranadóttir T, Chanchiri I, Ludvigsen Al-Mashhadi A, Berggreen Dall E, Rasch S, Johansen M, Haunstrup LM, Cunsolo G, Poulsen CB, Larsen TS, Husby S, Brown P, Hawkes EA, El-Galaly TC, Grønbæk K

doi: 10.1111/bjh.70082

Sarcoma

Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial

J Clin Oncol

Bisogno G, Chisholm J, Hladun R, De Salvo GL, Guerin F, Casanova M, Mandeville H, Alaggio R, Coppadoro B, Orbach D, Ferrari A, van Rijn R, Defachelles AS, Ben-Arush M, Glosli H, Cesen M, Merks JHM, Minard-Colin V

doi: 10.1200/JCO-24-02850

Lymphoma

Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: an ancillary study from the BLOCAGE trial

Neuro Oncol

Hernández-Verdin I, Kirasic E, Mokhtari K, Barillot N, Rincón de la Rosa L, Sourdeau E, Abada Y, Le Tarff-Tavernier M, Nichelli L, Rozenblum L, Kas A, Mathon B, Choquet S, Houillier C, Hoang-Xuan K, Alentorn A

doi: 10.1093/neuonc/noaf059

Gastrointestinal Cancer

Survival benefit of adjuvant chemotherapy in elderly patients with UICC stage III colon carcinoma: A 20-year population-based German cohort study

Eur J Cancer

Langheinrich M, Gerken M, Robers G, Hansinger J, Franke B, Lacruz ME, Mueller-Nordhorn J, Schneider C, Reinwald F, Stang A, Sackmann A, Zeissig SR, Klinkhammer-Schalke M, Kersting S, Völkel V, Benz S

doi: 10.1016/j.ejca.2025.115583

Gastrointestinal Cancer

Twenty year survival of advanced gastrointestinal stromal tumours treated with imatinib Exploratory long-term follow-up of the BFR14 trial

Ann Oncol

Blay JY, Devin Q, Toulmonde M, Dufresne A, Penel N, Adenis A, Rios M, Bertucci F, Duffaud F, Firmin N, Valentin T, Bompas E, Collard O, Pracht M, Hervieu A, Verret B, Ray-Coquard I, Cassier P, Henon C, Perol D, Italiano A, Chabaud S, Le Cesne A

doi: 10.1016/j.annonc.2025.05.535

Skin Cancer

Evaluation of residual tumour in wide local excision for melanoma: A nationwide population-based study

Eur J Cancer

Schurink AW, Verhoef C, Waalboer-Spuij R, Mooyaart A, Grünhagen DJ

doi: 10.1016/j.ejca.2025.115364

Lung, Respiratory and Thoracic Cancer

Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis

Lancet Oncol

Di Federico A, Stumpo S, Mantuano F, De Giglio A, Lo Bianco F, Pecci F, Alessi JV, Wang X, Sperandi F, Melotti B, Gelsomino F, Skoulidis F, Garassino MC, Peters S, Awad MM, Ardizzoni A, Ricciuti B

doi: 10.1016/S1470-2045(25)00429-2

Related content

Survival of European adolescents and young adults diagnosed with central nervous system tumours and comparison with younger and older age groups: EUROCARE-6 results

Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study

Secondary central nervous system lymphoma (SCNSL) in mantle cell lymphoma (MCL): Characteristics and risk factors in a Danish nationwide population-based study

Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial

Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: an ancillary study from the BLOCAGE trial

Survival benefit of adjuvant chemotherapy in elderly patients with UICC stage III colon carcinoma: A 20-year population-based German cohort study

Twenty year survival of advanced gastrointestinal stromal tumours treated with imatinib Exploratory long-term follow-up of the BFR14 trial

Evaluation of residual tumour in wide local excision for melanoma: A nationwide population-based study

Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis